High blood pressure, antihypertensive medication and lung function in a general adult population

Respiratory Research

Volumn 12, Issue 1, 2011, Pages

  Schnabel, Eva ^a,b   Karrasch, Stefan ^a,b,c   Schulz, Holger ^a,c   Gläser, Sven ^d   Meisinger, Christa ^a,e   Heier, Margit ^a,e   Peters, Annette ^a,c   Wichmann, H Erich ^a,c   Behr, Jürgen ^b,c   Huber, Rudolf M ^c   Heinrich, Joachim ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e KLINIKUM AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTHROPOMETRY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; GERMAN (CITIZEN); HUMAN; HYPERTENSION; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POPULATION RESEARCH; SEX DIFFERENCE; SMOKING; BLOOD PRESSURE; DRUG EFFECT; GERMANY; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY; TREATMENT OUTCOME; VITAL CAPACITY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; FEMALE; FORCED EXPIRATORY VOLUME; GERMANY; HUMANS; HYPERTENSION; LUNG; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SPIROMETRY; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 79954612490     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-50     Document Type: Article

References (26)

1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J: Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004,22(1):11-19.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003,42(6):1206-1252.
3. Flack JM, Peters R, Shafi T, Alrefai H, Nasser SA, Crook E: Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol 2003,14(7 Suppl 2):S92-S98.
4. Engstrom G, Hedblad B, Valind S, Janzon L: Increased incidence of myocardial infarction and stroke in hypertensive men with reduced lung function. J Hypertens 2001,19(2):295-301.
5. Enright PL, Kronmal RA, Smith VE, Gardin JM, Schenker MB, Manolio TA: Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest 1995,107(1):28-35.
6. Margretardottir OB, Thorleifsson SJ, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gislason T: Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study. COPD 2009,6(4):250-255.
7. Selby JV, Friedman GD, Quesenberry CP Jr: Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990,131(6):1017-1027.
8. Sparrow D, Weiss ST, Vokonas PS, Cupples LA, Ekerdt DJ, Colton T: Forced vital capacity and the risk of hypertension. The Normative Aging Study. Am J Epidemiol 1988,127(4):734-741.
9. Wu Y, Vollmer WM, Buist AS, Tsai R, Cen R, Wu X, Chen P, Li Y, Guo C, Mai J, Davis CE: Relationship between lung function and blood pressure in Chinese men and women of Beijing and Guangzhou. PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group. Int J Epidemiol 1998,27(1):49-56.
10. Doshan HD, Rosenthal RR, Brown R, Slutsky A, Applin WJ, Caruso FS: Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. J Cardiovasc Pharmacol 1986,8(Suppl 4):S105-S108.
11. Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB: Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008,63(4):301-305.
12. Mcneill RS: Effect of a beta-adrenergic-blocking agent, propranolol, on asthmatics. Lancet 1964,2(7369):1101-1102.
13. Salpeter S, Ormiston T, Salpeter E: Cardioselective beta-blockers for reversible airway disease. Cochrane Database Syst Rev 2002, 1:CD002992.
14. Salpeter S, Ormiston T, Salpeter E: Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005, 4:CD003566.
15. van Gestel YR, Hoeks SE, Sin DD, Welten GM, Schouten O, Witteveen HJ, Simsek C, Stam H, Mertens FW, Bax JJ, van Domburg RT, Poldermans D: Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med 2008,178(7):695-700.
16. van Zyl AI, Jennings AA, Bateman ED, Opie LH: Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. Chest 1989,95(1):209-213.
17. Nelson SB, Gardner RM, Crapo RO, Jensen RL: Performance evaluation of contemporary spirometers. Chest 1990,97(2):288-297.
18. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993.,16(5-40):
19. Mühlberger N, Behrend C, Stark R: Datenbankgestützte Online-Erfassung von Arzneimitteln im Rahmen gesundheitswissenschaftlicher Studien - Erfahrungen mit der IDOM-Software. Informatik Biometrie Epidemiologie Medizin Biologie 2003.,34(601-611):
20. Hochdruckliga Deutsche: Empfehlung zur Hochdruckbehandlung. 19 Auflage 2007.
21. Antonelli-Inc, Pedone C: Respiratory effects of beta-adrenergic receptor blockers. Curr Med Chem 2007,14(10):1121-1128.
22. Martineau L, Horan MA, Rothwell NJ, Little RA: Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci (Lond) 1992,83(5):615-621.
23. Angulo M, Taranto E, Soto JP, Malacrida L, Nin N, Hurtado FJ, Piriz H: Salbutamol improves diaphragmatic contractility in chronic airway obstruction. Arch Bronconeumol 2009,45(5):230-234.
24. Grimm DR, Schilero GJ, Spungen AM, Bauman WA, Lesser M: Salmeterol improves pulmonary function in persons with tetraplegia. Lung 2006,184(6):335-339.
25. Frankenstein L, Nelles M, Meyer FJ, Sigg C, Schellberg D, Remppis BA, Katus HA, Zugck C: Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment. Eur J Cardiovasc Prev Rehabil 2009,16(4):424-429.
26. Engstrom G, Wollmer P, Valind S, Hedblad B, Janzon L: Blood pressure increase between 55 and 68 years of age is inversely related to lung function: longitudinal results from the cohort study 'Men born in 1914'. J Hypertens 2001,19(7):1203-1208.